Protein Sources Urinary Stone Risk
The Effect of Protein Sources on Urinary Stone Risk
1 other identifier
interventional
14
1 country
1
Brief Summary
Prior studies have shown that the source of dietary protein can have a significant impact on urinary stone risk. However, whey and plant protein isolates have not been compared. This is an important distinction as protein supplements fortified foods are increasingly popular. Herein, we seek to investigate the effect of different protein supplements, in an otherwise identical diet, on urinary stone risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedStudy Start
First participant enrolled
October 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedApril 24, 2023
April 1, 2023
8 months
July 12, 2022
April 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Urinary stone risk
24 hour urine panel and supersaturation for Calcium Oxalate and Uric Acid
3 months after beginning study
Calcium Oxalate Inhibitor activity
mmol of Oxalate added before spontaneous precipitation
3-6 months after beginning study
Study Arms (4)
Pea protein diet
EXPERIMENTALWhey protein diet
EXPERIMENTALSoy protein
EXPERIMENTALRice protein
EXPERIMENTALInterventions
Participants will receive a diet supplemented by the above protein
Eligibility Criteria
You may qualify if:
- Willing and able to complete the study
- Healthy with no personal or family history of kidney stones
You may not qualify if:
- Allergy to any protein isolates or menu items used in the study
- History of calcium oxalate, cysteine, uric acid, or infection stones
- Disorders of absorption: Celiac disease, Irritable Bowel Disease, chronic diarrhea, short gut
- Systemic predisposition to stones: gout, congenital hyperuricemia, chronic diarrhea, insulin resistance, neoplastic disorders, hyperparathyroidism or renal tubular acidosis
- Women who are currently pregnant or planning pregnancy within 2 years
- Renal transplant recipient
- Bedridden study participants (ECOG ≥ 3)
- Uncorrected anatomical obstruction of the urinary tract
- History of recurrent urinary tract infections (\> 3 urinary tract infections/year proven by urine culture)
- Chronic use of lithium
- Long-term glucocorticoid use (\> 7.5 mg prednisone daily for \> 30 days prior to enrollment)
- Intake of narcotic medication on a daily basis for \>30 days prior to enrollment
- Supplemental Vitamin C (\> 1 g daily)
- Carbonic anhydrase inhibitors (acetazolamide, topiramate, zonisamide)
- high dose calcium supplementation (\> 1,200 mg daily)
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 15, 2022
Study Start
October 30, 2022
Primary Completion
June 30, 2023
Study Completion
July 30, 2023
Last Updated
April 24, 2023
Record last verified: 2023-04